MF-094   Click here for help

GtoPdb Ligand ID: 14645

Synonyms: analog 31 [PMID: 29935771] | compound #4c [US10968172] | MF094
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: MF-094 is a selective inhibitor of ubiquitin specific peptidase 30 (USP30) [2]. It is one of the claims in patent US10968172B2 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 11
Topological polar surface area 112.75
Molecular weight 535.7
XLogP 3.66
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)(C)NS(=O)(=O)C1=CC=CC2=C(C=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)C4CCCCC4
Isomeric SMILES CC(C)(C)NS(=O)(=O)C1=CC=CC2=C1C=CC=C2NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)C4CCCCC4
InChI InChI=1S/C30H37N3O4S/c1-30(2,3)33-38(36,37)27-19-11-16-23-24(27)17-10-18-25(23)31-29(35)26(20-21-12-6-4-7-13-21)32-28(34)22-14-8-5-9-15-22/h4,6-7,10-13,16-19,22,26,33H,5,8-9,14-15,20H2,1-3H3,(H,31,35)(H,32,34)/t26-/m0/s1
InChI Key DQXORJHBZHLLTE-SANMLTNESA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Kluge A, Lagu B, Maiti P, Panigrahi SK. (2021)
USP30 inhibitors.
Patent number: US10968172B2. Assignee: Astellas Engineered Small Molecules US Inc. Priority date: 14/05/2018. Publication date: 06/04/2021.
2. Kluge AF, Lagu BR, Maiti P, Jaleel M, Webb M, Malhotra J, Mallat A, Srinivas PA, Thompson JE. (2018)
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.
Bioorg Med Chem Lett, 28 (15): 2655-2659. [PMID:29935771]
3. Li X, Wang T, Tao Y, Wang X, Li L, Liu J. (2022)
MF-094, a potent and selective USP30 inhibitor, accelerates diabetic wound healing by inhibiting the NLRP3 inflammasome.
Exp Cell Res, 410 (2): 112967. [PMID:34883112]